Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) ...
Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
River Journal7h
Westchester’s Top Students Scientists Feted at Regeneron Event
Regeneron hosted a celebration to recognize the achievements of the 17 students selected as the Westchester 2025 Regeneron Science Talent Search Scholars. Beginning in 1942, the contest […] ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
February 4, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and ...
Zacks.com on MSN2d
Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend
Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in the ...
Yahoo21d
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
“All of this health information—their health records and the biospecimens—are coming to us de-identified,” Regeneron spokesperson Ella Campbell tells Fortune. “We have all of these data ...
MarketWatch24d
Regeneron Working with Truveta's Network to Extend Database
The center will have exclusive rights to perform all research-related sequencing on samples collected under the collaboration, Regeneron said. Both Regeneron and Truveta will use the data to ...
FiercePharma23d
JPM25: Regeneron CEO says it needs more 'arrows in its quiver' as Eylea HD sales fall short
Regeneron also hopes for a retinal vein occlusion ... We know the retinal community very well. But we didn’t have all the tools necessary to optimize Eylea HD.” Roche's Vabysmo will rise ...
Nasdaq24d
Regeneron and Truveta Announce Strategic Collaboration for the Truveta Genome Project, Aiming to Expand Genetic Database and Accelerate Drug Discovery
Regeneron collaborates with Truveta to expand ... up to ten million additional de-identified patient volunteers, all with linked electronic health records (EHRs). This novel resource is designed ...
Yahoo Finance24d
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database
Regeneron pledged $119.5m while Illumina is ... of the party’s pledge to fix the National Health Service (NHS). The All of Us Research Program (AOR) from the National Institutes of Health ...